Long Term Real-World Patient-Reported Outcomes with Risanki-zumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry

被引：0
|
作者：
Strober, Bruce E. [1 ,2 ]
Ferris, Laura K. [3 ]
Duffin, Kristina Callis [4 ]
Janak, Jud C. [5 ]
Sima, Adam P. [5 ]
Eckmann, Thomas [5 ]
Patel, Manish [6 ]
Photowala, Huzefa [6 ]
Garg, Vishvas [6 ]
Armstrong, April W. [7 ]
机构：
[1] Yale Univ, New Haven, CT USA
[2] Cent Connecticut Dermatol Res, Cromwell, CT USA
[3] Univ Pittsburgh, Pittsburgh, PA USA
[4] Univ Utah, Dept Dermatol, Salt Lake City, UT USA
[5] CorEvitas LLC, Waltham, MA USA
[6] AbbVie Inc, N Chicago, IL USA
[7] Univ Southern Calif, Los Angeles, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB189 / AB189
页数：1
相关论文
共 50 条
  • [1] Real-world patient-reported outcomes with risankizumab in patients with moderate to severe psoriasis from the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura K.
    Duffin, Kristina Callis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101
  • [2] Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura
    Duffin, Kristina Callis
    Janak, Jud C.
    Sima, Adam P.
    Eckmann, Thomas
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Armstrong, April
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : 82 - 90
  • [3] Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
    Armstrong, April W.
    Ferris, Laura K.
    Duffin, Kristina Callis
    Janak, Jud C.
    Sima, Adam P.
    Eckmann, Thomas
    Photowala, Huzefa
    Patel, Manish
    Garg, Vishvas
    Strober, Bruce E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB62 - AB62
  • [4] Real-world treat-to-target skin clearance with risankizumab in patients with moderate to severe psoriasis from the CorEvitas Psoriasis Registry
    Armstrong, April W.
    Ferris, Laura K.
    Duffin, Kristina Callis
    Janak, Jud
    Sima, Adam
    Eckmann, Thomas
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Strober, Bruce
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB200 - AB200
  • [5] Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry
    Strober, Bruce
    Duffin, Kristina Callis
    Lebwohl, Mark
    Sima, Adam
    Janak, Jud
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Bagel, Jerry
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01) : 2287401
  • [6] The National Psoriasis Foundation psoriasis treatment targets in real-world patients: prevalence and association with patient-reported outcomes in the Corrona Psoriasis Registry
    Merola, J. F.
    Chada, L. M. Perez
    Siegel, M.
    Bagel, J.
    Evans, C.
    Lockshin, B.
    Mason, M.
    Guo, N.
    McLean, R. R.
    Greenberg, J. D.
    Van Voorhees, A. S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (09) : 2051 - 2058
  • [7] ESPRIT registry nine-year interim real-world safety, effectiveness, and patient-reported outcomes of adalimumab for moderate to severe psoriasis
    Wu, Jashin J.
    Abramovits, William
    Valdecantos, Wendell C.
    Bereswill, Mareike
    Arikan, Dilek
    Guo, Dianlin
    Kupper, Hartmut
    Singh, Rakesh
    Menter, Alan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB206 - AB206
  • [8] Characterization of Patient-reported Outcomes in moderate to severe Psoriasis
    Radtke, M. A.
    Schmitt-Rau, K. H.
    Krenzer, S.
    Augustin, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 126 - 126
  • [9] Characterization of Patient-Reported Outcomes in Moderate to Severe Psoriasis
    Krenzer, Stefanie
    Radtke, Marc
    Schmitt-Rau, Karlheinz
    Augustin, Matthias
    DERMATOLOGY, 2011, 223 (01) : 80 - 86
  • [10] Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry
    Jessica A. Walsh
    Kristina Callis Duffin
    Abby S. Van Voorhees
    Soumya D. Chakravarty
    Timothy Fitzgerald
    Amanda Teeple
    Katelyn Rowland
    Jonathan Uy
    Robert R. McLean
    Wendi Malley
    Angel Cronin
    Joseph F. Merola
    Dermatology and Therapy, 2022, 12 : 97 - 119
12345